Our Biopharma Industry Is A Critical National Security Asset, And Disarming It Before The Next Pandemic Is Folly

Forbes December 16, 2021
John Osborn

Since at least January 2000, when Vice President Gore addressed the United Nations Security Council on the importance of combatting AIDS globally in January 2000, the United States government has regarded significant global public health threats as a matter of America’s national security. Former FDA Commissioner Dr. Scott Gottlieb has urged the United States to treat pandemic threats from infectious diseases as a preeminent national security threat and leverage our intelligence agencies in doing so.

Indeed, the most recent Covid-19 variant Omicron is a stark reminder that the threat posed by the next global virus presents a clear national security risk to the American people that should sharpen our collective focus on the strategic import of investing in biopharmaceutical...

Today's Sponsors

Today's Sponsor